Annual Total Liabilities
$9.65 M
+$1.88 M+24.22%
December 31, 2023
Summary
- As of February 7, 2025, EVOK annual total liabilities is $9.65 million, with the most recent change of +$1.88 million (+24.22%) on December 31, 2023.
- During the last 3 years, EVOK annual total liabilities has fallen by -$3.00 million (-23.72%).
- EVOK annual total liabilities is now -51.21% below its all-time high of $19.78 million, reached on December 31, 2012.
Performance
EVOK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$9.77 M
+$295.10 K+3.12%
September 30, 2024
Summary
- As of February 7, 2025, EVOK quarterly total liabilities is $9.77 million, with the most recent change of +$295.10 thousand (+3.12%) on September 30, 2024.
- Over the past year, EVOK quarterly total liabilities has increased by +$118.30 thousand (+1.23%).
- EVOK quarterly total liabilities is now -50.61% below its all-time high of $19.78 million, reached on December 31, 2012.
Performance
EVOK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EVOK Total Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +24.2% | +1.2% |
3 y3 years | -23.7% | +15.7% |
5 y5 years | +490.3% | +15.7% |
EVOK Total Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +37.5% | at high | +39.2% |
5 y | 5-year | -23.7% | +378.8% | -22.8% | +469.1% |
alltime | all time | -51.2% | +2784.3% | -50.6% | -100.0% |
Evoke Pharma Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $9.77 M(+3.1%) |
Jun 2024 | - | $9.47 M(+5.7%) |
Mar 2024 | - | $8.96 M(-7.2%) |
Dec 2023 | $9.65 M(+24.2%) | $9.65 M(+10.6%) |
Sep 2023 | - | $8.73 M(+3.4%) |
Jun 2023 | - | $8.44 M(+6.7%) |
Mar 2023 | - | $7.91 M(+1.9%) |
Dec 2022 | $7.77 M(+10.7%) | $7.77 M(-1.4%) |
Sep 2022 | - | $7.88 M(+9.2%) |
Jun 2022 | - | $7.21 M(+1.7%) |
Mar 2022 | - | $7.09 M(+1.1%) |
Dec 2021 | $7.02 M(-44.5%) | $7.02 M(+2.1%) |
Sep 2021 | - | $6.88 M(-40.7%) |
Jun 2021 | - | $11.59 M(+0.9%) |
Mar 2021 | - | $11.48 M(-9.2%) |
Dec 2020 | $12.65 M(+527.7%) | $12.65 M(+45.8%) |
Sep 2020 | - | $8.67 M(+0.4%) |
Jun 2020 | - | $8.64 M(+403.5%) |
Mar 2020 | - | $1.72 M(-14.8%) |
Dec 2019 | $2.02 M(+23.3%) | $2.02 M(-6.5%) |
Sep 2019 | - | $2.15 M(+67.6%) |
Jun 2019 | - | $1.28 M(-0.2%) |
Mar 2019 | - | $1.29 M(-21.2%) |
Dec 2018 | $1.63 M | $1.63 M(+1.5%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2018 | - | $1.61 M(+27.2%) |
Jun 2018 | - | $1.27 M(+5.9%) |
Mar 2018 | - | $1.20 M(-79.3%) |
Dec 2017 | $5.78 M(+4.9%) | $5.78 M(-33.6%) |
Sep 2017 | - | $8.70 M(+36.2%) |
Jun 2017 | - | $6.39 M(-7.5%) |
Mar 2017 | - | $6.90 M(+25.4%) |
Dec 2016 | $5.51 M(-9.2%) | $5.51 M(-9.9%) |
Sep 2016 | - | $6.11 M(-0.9%) |
Jun 2016 | - | $6.16 M(+0.8%) |
Mar 2016 | - | $6.12 M(+0.8%) |
Dec 2015 | $6.07 M(+0.4%) | $6.07 M(-4.8%) |
Sep 2015 | - | $6.38 M(+1.3%) |
Jun 2015 | - | $6.30 M(+1.7%) |
Mar 2015 | - | $6.19 M(+2.4%) |
Dec 2014 | $6.04 M(+58.9%) | $6.04 M(+255.5%) |
Sep 2014 | - | $1.70 M(-8.3%) |
Jun 2014 | - | $1.85 M(-55.0%) |
Mar 2014 | - | $4.12 M(+8.2%) |
Dec 2013 | $3.80 M(-80.8%) | $3.80 M(-15.8%) |
Sep 2013 | - | $4.52 M(>+9900.0%) |
Jun 2013 | - | $0.00(-100.0%) |
Mar 2013 | - | $1.70 M(-91.4%) |
Dec 2012 | $19.78 M(+5811.9%) | $19.78 M |
Dec 2011 | $334.50 K | - |
FAQ
- What is Evoke Pharma annual total liabilities?
- What is the all time high annual total liabilities for Evoke Pharma?
- What is Evoke Pharma annual total liabilities year-on-year change?
- What is Evoke Pharma quarterly total liabilities?
- What is the all time high quarterly total liabilities for Evoke Pharma?
- What is Evoke Pharma quarterly total liabilities year-on-year change?
What is Evoke Pharma annual total liabilities?
The current annual total liabilities of EVOK is $9.65 M
What is the all time high annual total liabilities for Evoke Pharma?
Evoke Pharma all-time high annual total liabilities is $19.78 M
What is Evoke Pharma annual total liabilities year-on-year change?
Over the past year, EVOK annual total liabilities has changed by +$1.88 M (+24.22%)
What is Evoke Pharma quarterly total liabilities?
The current quarterly total liabilities of EVOK is $9.77 M
What is the all time high quarterly total liabilities for Evoke Pharma?
Evoke Pharma all-time high quarterly total liabilities is $19.78 M
What is Evoke Pharma quarterly total liabilities year-on-year change?
Over the past year, EVOK quarterly total liabilities has changed by +$118.30 K (+1.23%)